For research use only. Not for therapeutic Use.
Fingolimod (FTY-720A, FTY720)(Cat No.:A000316)is an oral immunomodulating medication used to treat relapsing forms of multiple sclerosis (MS). It works by binding to sphingosine-1-phosphate receptors, sequestering lymphocytes in lymph nodes, and preventing them from reaching the central nervous system, thereby reducing inflammation and neurodegeneration. Fingolimod effectively decreases the frequency of MS relapses and delays disability progression. Its unique mechanism offers a valuable alternative to traditional MS therapies. With a favorable safety profile and proven efficacy, Fingolimod improves the quality of life for patients managing this chronic neurological disorder.
Catalog Number | A000316 |
CAS Number | 162359-56-0 |
Synonyms | NA |
Molecular Formula | C₁₉H₃₃NO₂.HCl |
Purity | ≥95% |
Target | S1P receptor |
Solubility | >17.2mg/mL in DMSO |
Storage | 3 years -20C powder |
IUPAC Name | 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol;hydrochloride |
InChI | InChI=1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H |
InChIKey | SWZTYAVBMYWFGS-UHFFFAOYSA-N |
SMILES | CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl |